BioSpace News Archive

Business

AbbVie and Voyager Therapeutics Launch $1.2 Billion+ Alzheimer’s Partnership

AbbVie and Voyager Therapeutics inked a collaboration deal to develop treatments for Alzheimer’s disease and other neurodegenerative diseases.

February 20, 2018

·

3 min read

·

Mark Terry

FDA

FDA Gives AstraZeneca’s Imfinzi the Nod for New Lung Cancer Indication

The U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Imfinzi to treat patients with unresectable Stage III non-small cell lung cancer (NSCLC).

February 20, 2018

·

3 min read

·

Mark Terry

Biotech Bay

Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B

Dynavax announced it has secured a $175 million non-dilutive term loan agreement to commercialize Heplisav-B.

February 20, 2018

·

2 min read

·

Alex Keown

Deals

PDL BioPharma Gives Up on Acquiring Neos Therapeutics

Nevada-based PDL BioPharma, Inc. said it will no longer pursue a proposed acquisition of Neos Therapeutics.

February 20, 2018

·

2 min read

·

Alex Keown

Gilead's $12B Bet Pays Off in Two Months After the

Biotech Bay

Federal Court Overturns Gilead Sciences and Merck Patent Dispute

Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision.

February 20, 2018

·

2 min read

·

Mark Terry

Drug Development

Aimmune Jumps On Phase III Peanut Allergy Trial Data

Aimmune Therapeutics announced late-stage trial results that showed its peanut allergy therapy was effective in more than 67 percent of juvenile patients.

February 20, 2018

·

2 min read

·

Alex Keown

Deals

J&J Could Explore Potential $2B Sale of Sterilization Products Division

Life sciences giant Johnson & Johnson may be shopping around its sterilization products division.

February 20, 2018

·

2 min read

·

Alex Keown

Genetown

MilliporeSigma Receives Two More Patents for CRISPR Technology

MilliporeSigma announced that the Korean Intellectual Property Office and the Israel Patent Office have each granted patent applications for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells.

February 20, 2018

·

4 min read

Business

Cook Medical Realigns One-Third of Its Global Workforce to Better Support Customers, Enable Future Growth and Provide Opportunity for Employees

These changes realign the current sales, marketing, research and development, and customer service teams in addition to establishing new distribution channel management and medical education teams.

February 20, 2018

·

3 min read

FDA

NeoTract Announces FDA Clearance of Expanded Indications for UroLift® System

These expanded indications mean that patients who have an obstructive median lobe and those as young as 45 are now eligible to receive treatment with the UroLift System for their BPH symptoms.

February 20, 2018

·

5 min read